Tsourdi, E., Zillikens, M. C., Meier, C., Body, J. J., Gonzalez Rodriguez, E., Anastasilakis, A. D., Abrahamsen, B., Mccloskey, E., Hofbauer, L. C., Guañabens, N., Obermayer-Pietsch, B., Ralston, S. H., Eastell, R., Pepe, J., Palermo, A.
& Langdahl, B. (2021).
Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS.
Journal of Clinical Endocrinology and Metabolism,
106(1), 264-281.
https://doi.org/10.1210/clinem/dgaa756